GUAN XUAN ET AL: "Gene therapy in monogenic congenital myopathies", METHODS, vol. 99, 14 October 2015 (2015-10-14), pages 91-98, XP029499274, ISSN: 1046-2023, DOI: 10.1016/J.YMETH.2015.10.004 (B1)

HARPER SCOTT Q ET AL: "Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy", NATURE MEDICINE, NATURE PUB. CO, NEW YORK, vol. 8, no. 3, 1 March 2002 (2002-03-01), pages 253-261, XP002604007, ISSN: 1078-8956 (B1)

HELLER ET AL: "379. MicroRNA-29 and Micro-Dystrophin Combinatorial Therapy Suppresses Fibrosis and Restores Function to mdx/utrn+/- Mice", MOLECULAR THERAPY, vol. 24, no. 1, 14 December 2016 (2016-12-14), page S151, XP055433385, DOI: 10.1016/S1525-0016(16)33188-4 (B1)

JAYNES, JB et al.: "Transcriptional Regulation ot the Muscle Creatine Kinase Gene and Regulated Expression in Transfected Mouse Myoblasts", Molecular and Cell Biology, vol. 6, no. 8, August 1986 (1986-08), pages 2855-2864, XP055541442, (B1)

LEDERFEIN, D et al.: "A 71-Kilodalton Protein is a Major Product of the Duchenne Muscular Dystrophy Gene in Brain and Other Nonmuscle Tissues", PNAS, vol. 89, no. 12, 15 June 1992 (1992-06-15) , pages 5346-5350, XP055541447, (B1)

WO-A1-2017/181014 (B1)

Paul T. Martin ET AL: "Translational Studies of GALGT2 Gene therapy for Duchenne Muscular Dystropy", , 1 January 2013 (2013-01-01), XP55535911, Retrieved from the Internet: URL:https://apps.dtic.mil/dtic/tr/fulltext /u2/a613577.pdf [retrieved on 2018-12-18] (B1)

US-A1- 2008 044 393 (B1)

WO-A1-2015/197232 (B1)

WO-A1-2016/177911 (B1)

MAJA Z SALVA ET AL: "Design of Tissue-specific Regulatory Cassettes for High-level rAAV-mediated Expression in Skeletal and Cardiac Muscle", MOLECULAR THERAPY, vol. 15, no. 2, 1 February 2007 (2007-02-01), pages 320-329, XP55078517, ISSN: 1525-0016, DOI: 10.1038/sj.mt.6300027 (B1)